東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Monocyte Phenotype and Whole Blood I...

University of Northern Colorado., Sport & Exercise Science.

Linked to FindBook

Google Book

Amazon

博客來

Monocyte Phenotype and Whole Blood Immune Response in Physically Active Chronic Cannabis Users and Non-users.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Monocyte Phenotype and Whole Blood Immune Response in Physically Active Chronic Cannabis Users and Non-users./
Author:	Lisano, Jonathon K.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
Description:	107 p.
Notes:	Source: Dissertations Abstracts International, Volume: 81-07, Section: B.
Contained By:	Dissertations Abstracts International81-07B.
Subject:	Immunology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27670199
ISBN:	9781392827598

Monocyte Phenotype and Whole Blood Immune Response in Physically Active Chronic Cannabis Users and Non-users.
Lisano, Jonathon K.

Monocyte Phenotype and Whole Blood Immune Response in Physically Active Chronic Cannabis Users and Non-users. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 107 p.

Source: Dissertations Abstracts International, Volume: 81-07, Section: B.

Thesis (Ph.D.)--University of Northern Colorado, 2019.

This item must not be sold to any third party vendors.

Some physically active individuals are now advocating for the use of cannabis with exercise for its potential to optimize the immune response. Yet, it remains to be seen whether the chronic use of cannabis products is linked to alterations in immune characteristics, such as monocyte phenotype and function in physically active individuals.The purpose of this cross-sectional study was to assess resting concentrations of c-reactive protein (CRP) and interleukin-6 (IL-6), monocyte phenotype and lipopolysaccharide (LPS) stimulated production of Interleukin-6 (IL-6) following pre-treated with synthetic cannabinoid 2 (CB2) receptor agonist and antagonist in physically active individuals using cannabis products at least 5-times per week for the past 6-months (CU) compared to physically active individuals who have not used any cannabis products in the past 6-months (NU).Physically active participants (N = 23; n = 11 CU and n = 12 NU) completed medical history, physical activity, and cannabis use surveys prior to assessment of their height, weight, body mass index (BMI), body fat percentage, resting heart rate and V̇O2max in their initial visit. In a subsequent visit, intravenous whole blood was collected following a 12-hour fast and 72-hours removed from last bout of vigorous exercise. Isolated serum was used to determine resting protein concentration of CRP and IL-6. Monocyte phenotype was analyzed using an Attune NxT flow cytometer following co-staining of CD-14 and CD-16. Supernatant from whole blood samples diluted with culture medium and stimulated for 24-hours with LPS following 1-hour pre-treatment with CB2 agonist and antagonist at a concentration of 1µM. Collected supernatant was analyzed for IL-6 using an ELISA. Data are presented as mean ± SD and were analyzed using SPSS using unpaired t-tests and ANOVA (α = 0.05). Pearson's correlations were calculated to determine meaningful relationships between primary outcome variables.There were no differences between CU and NU with respect to age, height, weight, BMI, body fat percentage, resting heart rate, or relative V̇O2max. There were no differences between the groups with respect to resting concentrations of CRP or IL-6. Total monocytes per mL of blood was significantly greater in CU (5.08 x 105 ± 1.63 x 105 cells/mL) when compared to NU (3.23 x 105 ± 1.20 x 105 cells/mL) (p = 0.01). The number of classical (CU: 3.77 x 105 ± 1.36 x 105 cells/mL; NU: 2.56 x 105 ± 0.97 x 105 cells/mL, p = 0.02) and intermediate monocytes (CU: 7.29 x 105 ± 5.19 x 105 cells/mL; NU: 2.32 x 105 ± 2.18 x 105 cells/mL, p = 0.01) were significantly greater in CU compared to NU. Cannabis users had a significantly greater relative percent of intermediate monocytes (CU: 13.89 ± 8.43%; NU: 6.33 ± 4.91%; p = 0.02), but there were no differences in classical (76.92 ± 8.48 %) or non-classical (12.73 ± 7.14 %) monocytes between the groups. There were no significant differences in stimulated production of IL-6 between CU and NU groups. Further, when the covariates of age, body fat percent, or monocytes/mL were used, there were no significant differences present between stimulated IL-6 production.Results from this study suggest that the chronic use of cannabis in physically active individuals may alter monocyte phenotype and count, but this was not related to changes in resting concentrations of inflammatory markers CRP and IL-6, nor does it alter whole blood LPS stimulated IL-6 release.

ISBN: 9781392827598Subjects--Topical Terms:

611031
Immunology.
Subjects--Index Terms:

Cannabidiol

Monocyte Phenotype and Whole Blood Immune Response in Physically Active Chronic Cannabis Users and Non-users.
LDR:04634nmm a2200361 4500 001 2266607
005 20200612084455.5
008 220629s2019 ||||||||||||||||| ||eng d
020 $a 9781392827598
035 $a (MiAaPQ)AAI27670199
035 $a AAI27670199
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lisano, Jonathon K. $3 3543818
245 1 0 $a Monocyte Phenotype and Whole Blood Immune Response in Physically Active Chronic Cannabis Users and Non-users.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 107 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-07, Section: B.
500 $a Advisor: Stewart, Laura K.
502 $a Thesis (Ph.D.)--University of Northern Colorado, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a Some physically active individuals are now advocating for the use of cannabis with exercise for its potential to optimize the immune response. Yet, it remains to be seen whether the chronic use of cannabis products is linked to alterations in immune characteristics, such as monocyte phenotype and function in physically active individuals.The purpose of this cross-sectional study was to assess resting concentrations of c-reactive protein (CRP) and interleukin-6 (IL-6), monocyte phenotype and lipopolysaccharide (LPS) stimulated production of Interleukin-6 (IL-6) following pre-treated with synthetic cannabinoid 2 (CB2) receptor agonist and antagonist in physically active individuals using cannabis products at least 5-times per week for the past 6-months (CU) compared to physically active individuals who have not used any cannabis products in the past 6-months (NU).Physically active participants (N = 23; n = 11 CU and n = 12 NU) completed medical history, physical activity, and cannabis use surveys prior to assessment of their height, weight, body mass index (BMI), body fat percentage, resting heart rate and V̇O2max in their initial visit. In a subsequent visit, intravenous whole blood was collected following a 12-hour fast and 72-hours removed from last bout of vigorous exercise. Isolated serum was used to determine resting protein concentration of CRP and IL-6. Monocyte phenotype was analyzed using an Attune NxT flow cytometer following co-staining of CD-14 and CD-16. Supernatant from whole blood samples diluted with culture medium and stimulated for 24-hours with LPS following 1-hour pre-treatment with CB2 agonist and antagonist at a concentration of 1µM. Collected supernatant was analyzed for IL-6 using an ELISA. Data are presented as mean ± SD and were analyzed using SPSS using unpaired t-tests and ANOVA (α = 0.05). Pearson's correlations were calculated to determine meaningful relationships between primary outcome variables.There were no differences between CU and NU with respect to age, height, weight, BMI, body fat percentage, resting heart rate, or relative V̇O2max. There were no differences between the groups with respect to resting concentrations of CRP or IL-6. Total monocytes per mL of blood was significantly greater in CU (5.08 x 105 ± 1.63 x 105 cells/mL) when compared to NU (3.23 x 105 ± 1.20 x 105 cells/mL) (p = 0.01). The number of classical (CU: 3.77 x 105 ± 1.36 x 105 cells/mL; NU: 2.56 x 105 ± 0.97 x 105 cells/mL, p = 0.02) and intermediate monocytes (CU: 7.29 x 105 ± 5.19 x 105 cells/mL; NU: 2.32 x 105 ± 2.18 x 105 cells/mL, p = 0.01) were significantly greater in CU compared to NU. Cannabis users had a significantly greater relative percent of intermediate monocytes (CU: 13.89 ± 8.43%; NU: 6.33 ± 4.91%; p = 0.02), but there were no differences in classical (76.92 ± 8.48 %) or non-classical (12.73 ± 7.14 %) monocytes between the groups. There were no significant differences in stimulated production of IL-6 between CU and NU groups. Further, when the covariates of age, body fat percent, or monocytes/mL were used, there were no significant differences present between stimulated IL-6 production.Results from this study suggest that the chronic use of cannabis in physically active individuals may alter monocyte phenotype and count, but this was not related to changes in resting concentrations of inflammatory markers CRP and IL-6, nor does it alter whole blood LPS stimulated IL-6 release.
590 $a School code: 0161.
650 4 $a Immunology. $3 611031
650 4 $a Physiology. $3 518431
653 $a Cannabidiol
653 $a Cannabis
653 $a Exercise
653 $a Immune response
653 $a Monocytes
690 $a 0982
690 $a 0719
710 2 $a University of Northern Colorado. $b Sport & Exercise Science. $3 1669326
773 0 $t Dissertations Abstracts International $g 81-07B.
790 $a 0161
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27670199